or Try an Advanced Search...

    ETF Components for JDOC - JPMorgan Healthcare Leaders ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    LLY C -0.36 8.98
    UNH C 0.45 7.23
    NVO C -0.47 5.37
    ABBV D -1.29 5.00
    REGN C -1.46 4.57
    DHR C 0.32 3.38
    JNJ F 0.15 3.02
    CI C 0.19 2.85
    SYK D -0.86 2.80

    Represented by ETF Holdings

    Keywords: S&P 500 Pharmaceutical Products Atopic Dermatitis Biopharmaceutical Bone Cardiovascular Disease Cholesterol Depressive Disorder Diabetes Disability Dow Jones Component Growth Hormone Immunology Infection Infectious Diseases Inflammation Insulin Medicaid Medicine Mental Health
    Industries: Drug Manufacturers - Major Biotechnology Health Care Plans Diagnostics & Research Medical Devices

    Recent News for JPMorgan Healthcare Leaders ETF & its Holdings

    Date Stock Title
    May 8 UNH Ascension warns of suspected cyberattack; clinical operations disrupted
    May 8 UNH Amedisys gains amid report of sweetened divestiture offer in UnitedHealth deal
    May 8 JNJ 10 Future Dividend Kings in the Next 5 Years or Less
    May 8 LLY Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
    May 8 NVO Wall Street Bulls Look Optimistic About Novo Nordisk (NVO): Should You Buy?
    May 8 DHR Danaher Corporation (DHR) Is a Trending Stock: Facts to Know Before Betting on It
    May 8 REGN Regeneron gene therapy improves hearing in child deafness
    May 8 JNJ Analysts' 3 Favorite Dividend Aristocrats, Based On Latest Price Targets
    May 8 ABBV QULIPTA™ (atogepant) Now Approved by Health Canada for the Preventive Treatment of Chronic Migraine in Adults
    May 8 REGN Regeneron gene therapy improves hearing in two children
    May 8 JNJ Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
    May 8 JNJ Neutrogena Lost Dermatologists and Missed Out on the $42 Billion Beauty Boom
    May 8 JNJ The Zacks Analyst Blog Highlights Tesla, Johnson & Johnson, Netflix, Abbott and ConocoPhillips
    May 8 REGN Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks
    May 7 LLY Hedge Fund Legend Druckenmiller Shares His Top Secrets For 30% Returns
    May 7 DHR Danaher declares $0.27 dividend
    May 7 DHR Danaher to Present at Bank of America Securities Healthcare Conference
    May 7 ABBV Teva Earnings Are Soon. What Could Keep the Stock Gains Going.
    May 7 JNJ 15 Best S&P 500 Dividend Stocks To Buy Now
    May 7 ABBV 15 Best S&P 500 Dividend Stocks To Buy Now
    The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
    Biotechnology Venture Capital Medical Technology Healthcare Service Healthcare Technology
    Back to the Main JDOC Page...